KEAP1 and triple-A syndrome: CTS protects against AAA by suppressing oxidative stress, inflammatory response, and pyroptosis while maintaining ECM equilibrium and the VSMC contractile phenotype via activating the Keap1-Nrf2 signaling axis through competitive binding to Keap1 at Arg415.